Skip to content

EA-ALte

The incidence and impact of an apparent life-threating event (ALTE) in children with esophageal atresia.* - EA-ALTE

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57705
Enrollment
300
Registered
2024-11-22
Start date
2025-12-12
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophagusatresia and oesophageal atresia

Interventions

none

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
16 Years to 64 Years

Inclusion criteria

Inclusion criteria: All children born between 01-01-2015 and 31-12-2024 diagnosed with Esophageal Atresia (EA), along with their parents and under treatment in one of the expertise centra; Erasmus MC, UMC Utrecht en Amsterdam UMC will be included in the study following the acquisition of informed consent

Exclusion criteria

Exclusion criteria: Children before the first discharge

Design outcomes

Primary

MeasureTime frame
- Incidence of ALTE in children diagnosed with an esophageal atresia within a home setting.** - Psychological impact on parents of ALTE and/or of having to perform BLS on their child with esophageal atresia

Secondary

MeasureTime frame
- Incidence of calling the emergency line (112) in response to ALTEs in children with EA** - Incidence of performing paediatric basic life support (PBLS) by parents - Intervention(s) performed by parents during an ALTE - Pathogenesis of ALTEs in children diagnosed with EA - (Surgical) management after an ALTE in children with an EA* - Aftercare and follow-up provided to parents after experiencing an ALTE with their child

Countries

Netherlands

Contacts

Public ContactA Berthelot

Erasmus MC, Universitair Medisch Centrum Rotterdam

john.vlot@erasmusmc.nl010-7040776

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 14, 2026